Antitrust Antitrust

Servier fails to revive ‘mitigation’ defense on appeal of UK NHS damage claim

Health services in the UK have defeated an attempt by Servier to bolster its defense against an antitrust damage claim related to hypertension drug perindopril.
The Court of Appeal in London ruled that a lower court had rightly handled disclosure questions over whether Servier could demand more evidence on how care

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Lewis Crofts


Lewis leads MLex's editorial strategy, content direction, quality and development. He has a reputation for breaking stories and providing analysis on complex legal disputes before regulators and courts around the globe. He has also developed MLex's unrivalled coverage of competition policy, litigation, regulation, Brexit and international investigations.

Discover MLex

Stay on top of global regulatory developments

Latest News